Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.61 USD | +3.95% | +3.39% | -41.92% |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Mar. 21 | Evoke Pharma, Inc. Announces Chief Executive Officer Changes as of March 31, 2024 | CI |
Evolution of the average Target Price on Evoke Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock
- Equities
- Stock Evoke Pharma, Inc. - Nasdaq
- Consensus Evoke Pharma, Inc.